1.Analysis of the risk factors for myelosuppression after concurrent chemoradiotherapy for patients with advanced non-small cell lung cancer. Support Care Cancer 2013; 21(3):785-791. 2.Clinical determinants of weight loss in patients with esophageal carcinoma during radiotherapy: a prospective longitudinal view. Asian Pac J Cancer Prev 2014; 5(15):1943-1948. 3.Predictors for weight loss in head and neckcancerpatients undergoing radiotherapy: a systematic review. Cancer Nurs 2015; 38(6):E37-45. 4.Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell cacinoma of head and neck: a meta-analysis. Sci Rep. 2015; 4(5):10798 5.Risk factors for late dysphagia after (chemo) radiotherapy for head and neck cancer: A systematic methodological review. Head Neck2016; 38(5):792-800. 6.Psychometric Properties of the Chinese Version of the M.D. Anderson Dysphagia Inventory for Head and Neck Cancer Patients. Cancer Nurs 2017;40(3):E9-E16. | 
